Welcome to LookChem.com Sign In|Join Free
  • or
N-[4-(2-chlorobenzoyl)pyridin-3-yl]-2,2-dimethylpropanamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

130418-28-9

Post Buying Request

130418-28-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

130418-28-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 130418-28-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,4,1 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 130418-28:
(8*1)+(7*3)+(6*0)+(5*4)+(4*1)+(3*8)+(2*2)+(1*8)=89
89 % 10 = 9
So 130418-28-9 is a valid CAS Registry Number.

130418-28-9Relevant academic research and scientific papers

Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase

Lumeras, Wenceslao,Caturla, Francisco,Vidal, Laura,Esteve, Cristina,Balagué, Cristina,Orellana, Adelina,Domínguez, María,Roca, Ramón,Huerta, Josep M.,Godessart, Núria,Vidal, Bernat

experimental part, p. 5531 - 5545 (2010/02/28)

A novel series of aminopyridine N-oxides were designed, synthesized, and tested for their ability to inhibit p38α MAP kinase. Some of these compounds showed a significant reduction in the LPS-induced TNFR production in human whole blood. Structure-activit

1, 7-NAPHTHYRIDINE DERIVATIVES AS P38 MAP KINASE INHIBITORS

-

Page/Page column 45, (2008/06/13)

This invention is directed to new inhibitors of the p38 mitogen-activated protein kinas having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.

NEW 4,8-DIPHENYL-POLYAZANAPHTHALENE DERIVATIVES

-

Page/Page column 59, (2008/12/08)

This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 130418-28-9